NCT05866627View on ClinicalTrials.gov

A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

July 4, 2023

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions
Healthy Volunteers
Interventions
DRUG

Famotidine

Specified dose on specified days

DRUG

Afimetoran

Specified dose on specified days

Trial Locations (1)

NG11 6JS

RECRUITING

Quotient Sciences, Nottingham

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05866627 - A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants | Biotech Hunter | Biotech Hunter